22.47 -0.53 (-2.30%)
1:35 PM ET 12/08/09
Company Profile
Price and Volume
Recent Price 23.00
52 Week High 24.50
52 Week Low 2.00
Avg. Daily Vol. (Mil) 0.29
Beta (3 year) 3.99
Share Related Items
Mkt Cap (Mil) 637.11
Shares Out (Mil) 27.70
Float (Mil) 24.95
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.70
Current Ratio 5.80
LT Debt/ Equity 0.05
Total Debt / Equity 0.08
Valuation Ratios
Price Earnings n.a.
Price/Sales 22.63
Price/Book 13.60
Price/Cash Flow -38.50
Per Share Data
Earnings -0.75
Sales 1.02
Book Value 1.69
Cash Flow -0.60
Business Summary
A biopharmaceutical company, which is engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of diseases and disorders of the central nervous system.
General Information
200 East First Street
Suite 300
Winston-Salem, NC 27101
www.targacept.com
Industry : Drugs
Sector: Health Care
Employees: 112
CEO: Dr. J. Donald deBethizy,
Short Interest
Current Month (Mil) 0.35
Previous Month (Mil) 0.27
Short Interest Ratio (Days) 1.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -22.00
Return on Investments -37.00
Profitability
Gross Margin n.a.
EBIT Margin -64.90
Profit Margin -65.40
Dow Jones S&P 500 NASDAQ 10-Year Note
10,293.83 1,094.05 2,180.44 33.79
Oil *
75.65
DOWN
96.28
DOWN
9.20
DOWN
9.17
DOWN
0.69
10 Yr
3.38%
SPDR Gold
111.94
-0.93%
-0.83%
-0.42%
-2.00%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services